Alpha-Amylase Inhibitor Screening Kit (Colorimetric) (ab283391) can be used to screen/characterize potential inhibitors of Alpha-Amylase.
Calcium-binding enzyme that initiates starch digestion in the oral cavity (PubMed:12527308). Catalyzes the hydrolysis of internal (1->4)-alpha-D-glucosidic bonds, yielding a mixture of maltose, isomaltose, small amounts of glucose as well as small linear and branched oligosaccharides called dextrins (PubMed:12527308).
Pancreatic alpha-amylase
AMY1, AMY1A, Alpha-amylase 1A, Salivary alpha-amylase
Alpha-Amylase Inhibitor Screening Kit (Colorimetric) (ab283391) can be used to screen/characterize potential inhibitors of Alpha-Amylase.
Alpha-Amylase Inhibitor Screening Kit (Colorimetric) (ab283391) can be used to screen/characterize potential inhibitors of Alpha-Amylase.
Alpha-Amylase enzyme is responsible for the breakdown of complex carbohydrates in humans. Thus, inhibition of α-amylase could be considered as a strategy for the treatment of disorders related to carbohydrate uptake, such as diabetes, obesity, dental cavities and periodontal diseases. In this kit human Alpha-Amylase hydrolyzes the synthetic substrate, yielding smaller fragments containing the chromophore (pNP; OD = 405 nm). A potent, specific inhibitor is also included in the kit.
The 1-step assay is simple and can be completed within 1 hour.
This product is manufactured by BioVision, an Abcam company and was previously called K482 a-Amylase Inhibitor Screening Kit. K482-100 is the same size as the 100 test size of ab283391.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Pancreatic alpha amylase also known as alpha-amylase P or AMY2A and salivary alpha amylase (AMY1) are enzymes that play essential roles in carbohydrate digestion. Mechanically they hydrolyze alpha-14-glycosidic linkages in starches breaking them down into smaller sugars like maltose and dextrins. Pancreatic alpha amylase has a molecular mass of approximately 56 kDa. The pancreas and salivary glands predominantly express these enzymes facilitating digestive processes in the small intestine and oral cavity respectively.
These alpha-amylases initiate the digestive process for dietary starches and glycogen by breaking them into sugars which are then more easily absorbed by the body. While they function largely independently their activity is supported by other digestive enzymes that further process carbohydrates throughout the digestive system. This enzymatic action is important for maintaining energy supply from glycogen and starches highlighting the significant role of alpha amylase in metabolic nutrition.
The catalytic action of pancreatic and salivary alpha amylase is a part of the digestive pathway for carbohydrates where it accelerates the breakdown of starches. These enzymes interact within the amylase pathway which includes other related enzymes like alpha-glucosidases that sequentially digest disaccharides into glucose. They are not known to form permanent complexes but work in conjunction with these digestive enzymes to facilitate efficient energy release.
Alterations in alpha-amylase activity have connections to conditions like pancreatitis and salivary gland dysfunctions where changes in enzyme levels provide important diagnostic information. Conditions such as pancreatitis an inflammation of the pancreas link directly to abnormal amylase activity and concentration. Additionally they associate with other proteins involved in inflammation and stress responses which are measured in clinical settings to assess pancreatic and salivary gland health.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Inhibition of Α−Amylase, Human Salivary (blue square) and Pancreas (green dot) by Α−Amylase Inhibitor. IC50 of Α−Amylase Inhibitor were calculated to be 108± 5 ng and 267 ± 4 ng, respectively.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com